Blog

Genova Diagnostics Partners with Neurocode to Launch Innovative Alzheimer’s Assessment

ASHEVILLE, N.C., Aug. 9, 2024 /PRNewswire/ — Genova Diagnostics, a global leader in clinical laboratory services, proudly announces the launch of its groundbreaking Alzheimer’s Assessment, a non-invasive blood test utilizing the p-Tau217 biomarker for early detection of Alzheimer’s disease. This initiative is enabled by a strategic partnership with Neurocode, a leading innovator in neurological diagnostics and research.

Read More »